Is the price fair?
What AZN's price assumes
AstraZeneca PLC trades at 26.4× earnings against 26.4× for the median Drug Manufacturers - General name, cheaper than its own group.
26.4
Trailing P/E · Drug Manufacturers - General median 26.4 · cheaper than the typical name in its group
- Price / sales
- 3.07
Price / sales · as of 2025-Q2
- Price / book
- 4.76
Price / book · as of 2025-Q2
- EV / sales
- 3.44
EV / sales
Details›
- Price / book2025-Q2
- 4.76
- EV / EBIT2025-Q2
- 17.0
- EV / sales2025-Q2
- 3.44
- Healthcare median P/E362 names
- 29.9
- Drug Manufacturers - General median P/E16 names
- 26.4
- Market capitalisation
- $288.0B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Drug Manufacturers - General
Ranks #3 of 7 by Smart Score